|
WO2008124331A1
|
|
Novel sequences and dna vaccines against avian flu
|
|
AU2007249158A1
|
|
Production of ssDNA in vivo
|
|
US2007160581A1
|
|
Production of ssDNA in vivo
|
|
AU2005314431A1
|
|
Cell free biosynthesis of high-quality nucleic acid and uses thereof
|
|
CN101103122A
|
|
Cell free biosynthesis of high-quality nucleic acid and uses thereof
|
|
WO2006037127A2
|
|
Single-stranded antimicrobial oligonucleotides and uses thereof
|
|
AU2004205192A1
|
|
Production of ssDNA in vivo
|
|
US2005020526A1
|
|
Oligodeoxynucleotide intervention for prevention and treatment of sepsis
|
|
US2005136393A1
|
|
Oligodoxynucleotide (ODN) libraries, their use in screening for antibacterial agents, and catalytic ODN sequence for use as an antibacterial agent
|
|
US2004248101A1
|
|
Identification of novel antibacteria agents by screening the single-stranded DNA expression library
|
|
AU2003265907A8
|
|
In vivo ssdna expression vectors for altering gene expression
|
|
WO03093424A2
|
|
In vivo ssdna expression vectors for altering gene expression
|
|
US2004235763A1
|
|
Treatment of HSV-related pathologies using ssDNA
|
|
US2003082800A1
|
|
In vivo ssDNA expression vectors for altering gene expression
|
|
WO0125419A1
|
|
ALTERING GENE EXPRESSION WITH ssDNA PRODUCED IN VIVO
|
|
EP1119615A1
|
|
Production of ssdna inside a cell
|
